Unknown

Dataset Information

0

TNP and its analogs: Modulation of IP6K and CYP3A4 inhibition.

ABSTRACT: Inositol hexakisphosphate kinase (IP6K) is an important mammalian enzyme involved in various biological processes such as insulin signalling and blood clotting. Recent analyses on drug metabolism and pharmacokinetic properties on TNP (N2-(m-trifluorobenzyl), N6-(p-nitrobenzyl)purine), a pan-IP6K inhibitor, have suggested that it may inhibit cytochrome P450 (CYP450) enzymes and induce unwanted drug-drug interactions in the liver. In this study, we confirmed that TNP inhibits CYP3A4 in type I binding mode more selectively than the other CYP450 isoforms. In an effort to find novel purine-based IP6K inhibitors with minimal CYP3A4 inhibition, we designed and synthesised 15 TNP analogs. Structure-activity relationship and biochemical studies, including ADP-Glo kinase assay and quantification of cell-based IP7 production, showed that compound 9 dramatically reduced CYP3A4 inhibition while retaining IP6K-inhibitory activity. Compound 9 can be a tool molecule for structural optimisation of purine-based IP6K inhibitors.

SUBMITTER: Lee S 

PROVIDER: S-EPMC8667942 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Inositol hexakisphosphate kinase (IP6K) is an important mammalian enzyme involved in various biological processes such as insulin signalling and blood clotting. Recent analyses on drug metabolism and pharmacokinetic properties on TNP (<i>N</i><sup>2</sup>-(<i>m</i>-trifluorobenzyl), <i>N</i><sup>6</sup>-(<i>p</i>-nitrobenzyl)purine), a pan-IP6K inhibitor, have suggested that it may inhibit cytochrome P450 (CYP450) enzymes and induce unwanted drug-drug interactions in the liver. In this study, we  ...[more]

Similar Datasets

Unknown Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis.
| S-EPMC6300986 | biostudies-literature
Unknown In Silico Prediction of the Metabolic Resistance of Vitamin D Analogs against CYP3A4 Metabolizing Enzyme.
| S-EPMC9322940 | biostudies-literature
Unknown CYP3A4-mediated lopinavir bioactivation and its inhibition by ritonavir.
| S-EPMC3250054 | biostudies-literature
Unknown Time-dependent inhibition of CYP3A4-mediated midazolam metabolism by macrolide antibiotics in CYP3A4 genetic variants: Comparison with testosterone metabolism.
| S-EPMC8795987 | biostudies-literature
Unknown Modulation of alpha-synuclein aggregation by dopamine analogs.
| S-EPMC2821914 | biostudies-literature
Unknown IP6K gene identification in plant genomes by tag searching.
| S-EPMC3090757 | biostudies-literature
Unknown Dataset of endo- and xenobiotic inhibition of CYP2B6: Comparison to CYP3A4.
| S-EPMC8914530 | biostudies-literature
Unknown Differential modulation of FXR activity by chlorophacinone and ivermectin analogs.
| S-EPMC5124510 | biostudies-literature
Unknown Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data.
| S-EPMC3056523 | biostudies-literature
Unknown Inhibition of DNA glycosylases via small molecule purine analogs.
| S-EPMC3857224 | biostudies-literature